SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-035141
Filing Date
2023-12-21
Accepted
2023-12-21 17:17:36
Documents
21
Period of Report
2023-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20231220_8k.htm   iXBRL 8-K 43902
2 EXHIBIT 3.1 ex_609370.htm EX-3.1 134275
3 EXHIBIT 4.1 ex_609178.htm EX-4.1 96914
4 EXHIBIT 4.2 ex_609179.htm EX-4.2 99449
5 EXHIBIT 10.1 ex_609180.htm EX-10.1 241999
6 EXHIBIT 10.2 ex_609181.htm EX-10.2 66101
7 EXHIBIT 99.1 ex_609128.htm EX-99.1 11252
12 m01.jpg GRAPHIC 5010
13 mbrx20231220_8kimg001.jpg GRAPHIC 3281
  Complete submission text file 0001437749-23-035141.txt   1007139

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20231220.xsd EX-101.SCH 3411
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20231220_def.xml EX-101.DEF 11806
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20231220_lab.xml EX-101.LAB 15850
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20231220_pre.xml EX-101.PRE 12021
15 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20231220_8k_htm.xml XML 2654
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671997 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 231506187
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)